Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Mason

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Virology|March 1, 1976
Complementation between BK human papovavirus and a simian virus 40 tsA mutantD H Mason, K K Takemoto
International Journal of Cancer|March 15, 1977
Transformation of rabbit kidney cells by BKV(MM) human papovavirusD H Mason, K K Takemoto
Journal of Pharmaceutical Sciences|April 3, 1999
Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR)R E Stevens, T Limsakun, G Evans, et al.
Neurology|April 1, 1997
Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosisS R Schwid, M D Petrie, M P McDermott, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Virology|March 1, 1976
Complementation between BK human papovavirus and a simian virus 40 tsA mutantD H Mason, K K Takemoto
International Journal of Cancer|March 15, 1977
Transformation of rabbit kidney cells by BKV(MM) human papovavirusD H Mason, K K Takemoto
Journal of Pharmaceutical Sciences|April 3, 1999
Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR)R E Stevens, T Limsakun, G Evans, et al.
Neurology|April 1, 1997
Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosisS R Schwid, M D Petrie, M P McDermott, et al.
Pageof 1